CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications

Review Article2021 Mar 16;143(11):1157-1172.

JOURNAL:Circulation. Article Link

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options

J Jankowski, J Floege, D Fliser et al. Keywords: chronic kidney disease; cardiovascular disease; pathophysiology; therapy

Full Text PDF